Partnering to Defeat Cancer

The ICR is one of the world's most influential cancer research organisations. Our discoveries have led to many new treatments for people with cancer, and we consistently rank at or near the top of national and international rankings of academic innovation, impact on society and research excellence.

We are well known for establishing productive partnerships with industry, along with major research successes such as our discovery of the prostate cancer drug abiraterone. We have more than 100 current partnerships with companies ranging from small, specialised biotech and medtech firms to big pharma.

Join ICR Chief Executive Professor Paul Workman, Associate Director of Business Development Dr Toby Richardson, ICR researchers and clinicians to learn more about our cutting-edge research, our culture of collaboration with industry, recent examples of our success and upcoming opportunities.

Hear about the benefits of cross-organisational working to both academia and industry in talks from Tony Jones, CEO of One Nucleus – the international life science and healthcare industry membership organisation, and from a key industry representative.

Most importantly, the afternoon will provide an opportunity to start conversations about how we can mutually share expertise to progress the discovery and development of potential cancer drugs and technologies to improve the lives of cancer patients and their families.

The event follows on from a successful meeting at The Royal Society in London, which led to several new opportunities for partnership between ICR researchers and industry partners.

Programme:

12.30  -  Registration and buffet lunch

13.00  -  Introduction    
Andy Carr, ICR

13.05   - Welcome & lunchtime briefing    
Professor Paul Workman, ICR

13.35  -  ICR Quick-Fire Showcase:
Professor Bissan Al-Lazikani
Professor Raj Chopra
Dr Anguraj Sadanandam

14.20  -  Tea break and networking

14.45 -  Working with the ICR
Niall Martin, Artios Pharma

15.00  -  ICR capabilities overview    
Dr Toby Richardson, ICR

15.15   - The importance of the business/academic relationship    
Dr. Tony Jones, One Nucleus

15.25  -  Closing remarks and thanks

15.30  -  Event finishes and networking opportunity